Today, Communia and a group of over 140 other organisations and individuals sent a letter to Director General of the World Intellectual Property Organization (WIPO) Francis Gurry, asking WIPO to ensure that intellectual property regimes support, and do not impede, efforts to both fighting the new Coronavirus outbreak and its consequences.
This diverse group representing researchers, educators, students, and the institutions that support them, acknowledges that a number of countries and some right holders have adopted exemplary measures in this context. These include measures to facilitate access to academic articles, research data, educational materials and other protected works, as well as medicines and medical devices that are subject to exclusive rights.
However, the signatories of the letter also believe that those measures alone are not enough, and that more actions are needed to ensure that the global intellectual property system prioritizes and promotes vital public interests at this critical moment.
Therefore, the signatories urge Mr. Gurry to use his position to guide the member states of WIPO and others in their response to intellectual property issues that the COVID-19 pandemic is raising, namely:
- Encouraging all WIPO member states to take advantage of flexibilities in the international system that permit uses of intellectual property-protected works for online education, for research and experimental uses, and for vital public interests, such as access to medicine and culture;
- Calling on all right holders to remove licensing restrictions that inhibit remote education, research (including for text and data mining and artificial intelligence projects) and access to culture, including across borders, both to help address the global pandemic, and in order to minimise the disruption caused by it;
- Supporting the call by Costa Rica for the World Health Organization to create a global pool of rights in COVID-19 related technology and data, as well as promoting the use of the Medicines Patents Pool, voluntary licensing, intellectual property pledges, compulsory licensing, use of competition laws, and other measures to eliminate barriers to the competitive global manufacture, distribution and sale of potentially effective products to detect, prevent, and treat COVID-19.
- Supporting countries’ rights to enact and use exceptions to trade secret and other intellectual property rights needed to facilitate greater access to manufacturing information, cell lines, confidential business information, data, software, product blueprints, manufacturing processes, and other subject matter needed to achieve universal and equitable access to COVID-19 medicines and medical technologies as soon as reasonably possible.
You can read the full letter here (PDF). You are welcome to endorse the letter here.
Update 7 April: the letter has been endorsed by more than 400 organisations and individuals in 45 countries. You can see the full list of signatories here.
Update 16 April: the letter has been endorsed by 149 organizations and 359 individuals. The listed organizations represent more than 32.5 million educators, 2.5 million libraries and archives, 45,000 museums, and 200 copyright scholars in 199 countries.
